Duvyzat (givinostat) / Italfarmaco  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duvyzat (givinostat) / Italfarmaco
2004-004854-19: A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate efficacy and safety of ITF 2357 in the management of patients with active moderate to severe Crohn’s disease

Ongoing
2
50
Europe
ITF2357, Capsule, hard
Italfarmaco S.p.A.
Crohn's disease
 
 
NCT01761968 / 2012-003499-37: Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

Active, not recruiting
2
90
Europe
givinostat, givinostat (ITF2357)
Italfarmaco
Chronic Myeloproliferative Neoplasms
12/26
12/26

Download Options